Newsletters
EARL
Joint EANM/SNMMI procedure guideline for the use of 177Lu-labeled PSMA-targeted radioligand-therapy (177Lu-PSMA-RLT)
Clemens Kratochwil, Wolfgang P. Fendler, Matthias Eiber, Michael S. Hofman, Louise Emmett, Jeremie Calais, Joseph R. Osborne, Amir Iravani, Phillip Koo, Liza Lindenberg, Richard P. Baum, Murat Fani Bozkurt, Roberto C. Delgado Bolton, Samer Ezziddin, Flavio Forrer, Rodney J. Hicks, Thomas A. Hope, Levent Kabasakal, Mark Konijnenberg, Klaus Kopka, Michael Lassmann, Felix M. Mottaghy, Wim J. G. Oyen, Kambiz Rahbar, Heiko Schoder, Irene Virgolini, Lisa Bodei, Stefano Fanti, Uwe Haberkorn & Ken Hermann
May 29, 2023
Joint EANM/SNMMI/IAEA enabling guide: how to set up a theranostics centre
Ken Herrmann, Luca Giovanella, Andrea Santos, Jonathan Gear, Pinar Ozgen Kiratli, Jens Kurth, Ana M. Denis-Bacelar, Roland Hustinx, Marianne Patt, Richard L. Wahl, Diana Paez, Francesco Giammarile, Hossein Jadvar, Neeta Pandit-Taskar, Munir Ghesani & Jolanta Kunikowska
EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds
M. Weber, M. Lam, C. Chiesa, M. Konijnenberg, M. Cremonesi, P. Flamen, S. Gnesin, L. Bodei, T. Kracmerova, M. Luster, E. Garin & K. Herrmann
The EANM guideline for radiosynoviorthesis
W.U. Kampen, B. Boddenberg-Pätzold, M. Fischer, M. Gabriel, R. Klett, M. Konijnenberg, E. Kresnik, H. Lellouche, F. Paycha, L. Terslev, C. Turkmen, F. van der Zant, L. Antunovic, E. Panagiotidis, G. Gnanasegaran, T. Kuwert, T. Van den Wyngaert on behalf of the EANM Bone & Joint Committee, the Dosimetry Committee, the Oncology & Theranostics Committee
EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands (177Lu-PSMA-RLT)
Clemens Kratochwil, Wolfgang Peter Fendler, Matthias Eiber, Richard Baum, Murat Fani Bozkurt, Johannes Czernin, Roberto C. Delgado Bolton, Samer Ezziddin, Flavio Forrer, Rodney J. Hicks, Thomas A. Hope, Levant Kabasakal, Mark Konijnenberg, Klaus Kopka, Michael Lassmann, Felix M. Mottaghy, Wim Oyen, Kambiz Rahbar, Heiko Schöder, Irene Virgolini, Hans-Jürgen Wester, Lisa Bodei, Stefano Fanti, Uwe Haberkorn & Ken Herrmann
EANM guidelines for radionuclide therapy of bone metastases with beta-emitting radionuclides
Daria Handkiewicz-Junak, Thorsten D. Poeppel, Lisa Bodei, Cumali Aktolun, Samer Ezziddin, Francesco Giammarile, Roberto C. Delgado-Bolton & Michael Gabriel
EANM guideline for radionuclide therapy with radium-223 of metastatic castration-resistant prostate cancer
Thorsten D. Poeppel, Daria Handkiewicz-Junak, Michael Andreeff, Alexander Becherer, Andreas Bockisch, Eva Fricke, Lilli Geworski, Alexander Heinzel, Bernd J. Krause, Thomas Krause, Markus Mitterhauser, Wilfried Sonnenschein, Lisa Bodei, Roberto C. Delgado-Bolton & Michael Gabriel
The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours
John J. Zaknun, L. Bodei, J. Mueller-Brand, M. E. Pavel, R. P. Baum, D. Hörsch, M. S. O’Dorisio, T. M. O’Dorisiol, J. R. Howe, M. Cremonesi & D. J. Kwekkeboom
ERRATUM: The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours
L. Bodei, J. Mueller-Brand, R. P. Baum, M. E. Pavel, D. Hörsch, M. S. O’Dorisio, T. M. O’Dorisio, J. R. Howe, M. Cremonesi, D. J. Kwekkeboom & J. J. Zaknun
EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds
Francesco Giammarile, Lisa Bodei, Carlo Chiesa, Glenn Flux, Flavio Forrer, Françoise Kraeber-Bodere, Boudewijn Brans, Bieke Lambert, Mark Konijnenberg, Françoise Borson-Chazot, Jan Tennvall, Markus Luster & the Therapy, Oncology and Dosimetry Committees
EANM procedure guidelines for therapy of benign thyroid disease
Marcel P. M. Stokkel, Daria Handkiewicz Junak, Michael Lassmann, Markus Dietlein & Markus Luster
EANM procedure guidelines for 131I-meta-iodobenzylguanidine (131I-mIBG) therapy
Francesco Giammarile, Arturo Chiti, Michael Lassmann, Boudewijn Brans & Glenn Flux
Guidelines for radioiodine therapy of differentiated thyroid cancer
M. Luster, S. E. Clarke, M. Dietlein, M. Lassmann, P. Lind, W. J. G. Oyen, J. Tennvall & E. Bombardieri
EANM procedure guideline for radio-immunotherapy for B-cell lymphoma with 90Y-radiolabelled ibritumomab tiuxetan (Zevalin)
M. Luster, S. E. Clarke, M. Dietlein, M. Lassmann, P. Lind, W. J. G. Oyen, J. Tennvall & E. Bombardieri